In the USA, patients with T2DM are treated with sitagliptin as monotherapy as an adjunct to diet and exercise, or in combination with metformin or TZD. Recently, the US FDA approved Janumet as ...
The combination of sitagliptin and metformin provided a more than additive effect on native GLP-1 concentrations. This combination may benefit patients with Type 2 diabetes through substantial ...
Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...
Sitagliptin and Metformin under the brand name of Dapanorm Trio ® at an affordable price for adults with Type 2 Diabetes in India. Speaking on the launch of Dapanorm Trio ®, Mr. Mohammed ...